Neonatal pulmonary hypertension: Urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function

New England Journal of Medicine

Volumn 344, Issue 24, 2001, Pages 1832-1838

  Pearson, DeLinda L ^a   Dawling, Sheila ^a   Walsh, William F ^a   Haines, Jonathan L ^a   Christman, Brian W ^a   Bazyk, Amy ^a   Scott, Nathan ^a   Summar, Marshall L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; CARBAMOYL PHOSPHATE SYNTHASE; NITRIC OXIDE; THREONINE; UREA;

AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; METABOLITE; NEWBORN; NEWBORN DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ARGININE; CARBON-NITROGEN LIGASES WITH GLUTAMINE AS AMIDE-N-DONOR; CASE-CONTROL STUDIES; CITRULLINE; FEMALE; GENETICS, POPULATION; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; POLYMORPHISM, GENETIC; UREA;

EID: 0035859237     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200106143442404     Document Type: Article

References (32)

1. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: Practice variation and outcomes
2. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
3. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
4. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn
5. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth
6. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs
7. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig
8. Endogenous nitric oxide and pulmonary vascular tone in the neonate
9. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
10. The L-arginine-nitric oxide pathway
11. Development of urea-synthesizing enzymes in human liver
12. Studies on urea cycle enzyme levels in the human fetal liver at different gestational ages
13. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine
14. Analysis of 200 patients undergoing bone marrow transplant shows allelic disequilibrium between drug related toxicity and a common exonic polymorphism in the CPSI gene and correlates with disruption of urea cycle intermediates
15. 15N]nitrate in biological fluids
16. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and S-nitrosothiols
17. Determination of nitrite/nitrate in human biological material by the simple Griess reaction
18. Plasma amino acid profiles during the first three days of life in infants with respiratory distress syndrome: Effect of parenteral amino acid supplementation
19. Regulation of pulmonary vascular tone in the perinatal period
20. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus
21. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries
22. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn
23. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension
24. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation
25. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages
26. Whole body arginine metabolism and nitric oxide synthesis in newborns with persistent pulmonary hypertension
27. Reference interval for human plasma nitric oxide end products
28. Nitric oxide and endothelin-1 during postnatal life
29. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population
30. Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease
31. Pulmonary and systemic arterial pressure in hyaline membrane disease
32. The preferred source of arginine for high-output nitric oxide synthesis in blood vessels